2nd Gene Therapy for Ophthalmic Disorders 2021
21 Septembre 2021 · 3 joursOnline, Etats-UnisOphtalmologieAnglais
OnlineÀ propos de ce congrès
Discover novel vectors and administration routes for optimal retinal delivery with 30+ world class speakers from the likes of GenSight Biologics, Biogen, Gyroscope Therapeutics, Novartis, Horama and REGENXBIO.
